ÂÜÀòÂÒÂ×

Alberto del Rio Espinola is Director of Translational Sciences at GentiBio. He holds Biotechnology and Biochemistry degrees from Autonoma de Barcelona University and his Ph.D. in pharmacogenetics of stroke acute therapy from Vall d’Hebron Hospital. During his time with Novartis in Basel, Switzerland, Alberto started as a computational biologist applying pharmacogenetics to safety endpoints, he went on to work in a project toxicologist role for advanced therapy programs and then led a laboratory using genome engineering as a tool to support safety evaluation. Alberto is certified by the American Board of Toxicology and by European Registry.